Patents by Inventor Hassan Heshmati

Hassan Heshmati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11628184
    Abstract: The present invention relates to methods of managing weight, and treating overweight or obesity and treating or preventing diabetes in a subject in need thereof. In one embodiment, the method comprises the steps of (a) orally administering to the subject from about 0.7 g to about 4 g of crosslinked carboxymethylcellulose; and (b) orally administering to the subject at least about 100 mL of water per gram of crosslinked carboxymethylcellulose. Steps (a) and (b) are conducted prior to or with at least one meal per day.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: April 18, 2023
    Assignee: Gelesis, LLC
    Inventors: Hassan Heshmati, Eyal S. Ron, Alessandro Sannino, Yishai Zohar
  • Publication number: 20210260099
    Abstract: The present invention relates to methods of managing weight, and treating overweight or obesity and treating or preventing diabetes in a subject in need thereof. In one embodiment, the method comprises the steps of (a) orally administering to the subject from about 0.7 g to about 4 g of crosslinked carboxymethylcellulose; and (b) orally administering to the subject at least about 100 mL of water per gram of crosslinked carboxymethylcellulose. Steps (a) and (b) are conducted prior to or with at least one meal per day.
    Type: Application
    Filed: February 17, 2021
    Publication date: August 26, 2021
    Inventors: Hassan Heshmati, Eyal S. Ron, Alessandro Sannino, Yishai Zohar
  • Patent number: 10953038
    Abstract: The present invention relates to methods of managing weight, and treating overweight or obesity and treating or preventing diabetes in a subject in need thereof. In one embodiment, the method comprises the steps of (a) orally administering to the subject from about 0.7 g to about 4 g of crosslinked carboxymethylcellulose; and (b) orally administering to the subject at least about 100 mL of water per gram of crosslinked carboxymethylcellulose. Steps (a) and (b) are conducted prior to or with at least one meal per day.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: March 23, 2021
    Assignee: Gelesis LLC
    Inventors: Hassan Heshmati, Eyal S. Ron, Alessandro Sannino, Yishai Zohar
  • Publication number: 20180153925
    Abstract: The present invention relates to methods of managing weight, and treating overweight or obesity and treating or preventing diabetes in a subject in need thereof. In one embodiment, the method comprises the steps of (a) orally administering to the subject from about 0.7 g to about 4 g of crosslinked carboxymethylcellulose; and (b) orally administering to the subject at least about 100 mL of water per gram of crosslinked carboxymethylcellulose. Steps (a) and (b) are conducted prior to or with at least one meal per day.
    Type: Application
    Filed: December 8, 2017
    Publication date: June 7, 2018
    Inventors: Hassan Heshmati, Eyal S. Ron, Alessandro Sannino, Yishai Zohar
  • Patent number: 9855294
    Abstract: The present invention relates to methods of managing weight, and treating overweight or obesity and treating or preventing diabetes in a subject in need thereof. In one embodiment, the method comprises the steps of (a) orally administering to the subject from about 0.7 g to about 4 g of crosslinked carboxymethylcellulose; and (b) orally administering to the subject at least about 100 mL of water per gram of crosslinked carboxymethylcellulose. Steps (a) and (b) are conducted prior to or with at least one meal per day.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: January 2, 2018
    Assignee: Gelesis, LLC
    Inventors: Hassan Heshmati, Eyal S. Ron, Alessandro Sannino, Yishai Zohar
  • Publication number: 20150366898
    Abstract: The present invention relates to methods of managing weight, and treating overweight or obesity and treating or preventing diabetes in a subject in need thereof. In one embodiment, the method comprises the steps of (a) orally administering to the subject from about 0.7 g to about 4 g of crosslinked carboxymethylcellulose; and (b) orally administering to the subject at least about 100 mL of water per gram of crosslinked carboxymethylcellulose. Steps (a) and (b) are conducted prior to or with at least one meal per day.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 24, 2015
    Inventors: Hassan Heshmati, Eyal S. Ron, Alessandro Sannino, Yishai Zohar
  • Publication number: 20070072907
    Abstract: Use of a pyrazole-derived compound that is an antagonist for cannabinoid CB1 receptors, alone or combined with another active principal, for preparing medicinal products that are useful in the prevention and treatment of dyslipidaemias and of diseases related to dyslipidaemias and/or to obesity, such as metabolic syndrome, cardiovascular risks and hepatic diseases.
    Type: Application
    Filed: April 24, 2006
    Publication date: March 29, 2007
    Applicant: sanofi-aventis
    Inventors: Michele Arnone, Jean Marc Herbert, Hassan Heshmati, Philip Janiak, Mohammed Bensaid